Non-Candida albicans Candida species: virulence factors and species identification in India

Document Type : Original Articles


1 Department of Microbiology, Uttar Pradesh University of Medical Sciences, Saifai, India

2 Department of Community Medicine, Gajra Raja Medical College, Gwalior, India



Background and Purpose: The predominant cause of candidiasis was Candida albicans which has recently changed to non-Candida albicans Candida (NCAC) (i.e., Candida spp. other than the C. albicans). The NCAC spp., earlier considered non-pathogenic or minimally virulent, are now considered a primary cause of morbidity and mortality in immunocompromised individuals. Given the NCAC spp.has become more common in clinical cases, this study aimed to determine the prevalence of NCAC spp. in different clinical specimens and assess a few of their virulence factors.
Materials and Methods: Routine samples for bacterial culture and sensitivity that showed colony characteristics, like Candida on Blood Agar and microscopic features resembling Candida spp., were processed further. Candida isolates underwent tests for chlamydospore formation and biochemical tests, including sugar fermentation and sugar assimilation tests. These were grown at 42oC, and their colony color was identified using HiCrome™ Candida Differential Agar (HiMedia Laboratories Pvt. Ltd., Mumbai,India), HiCandidaTM Identification Kit (HiMedia Laboratories Pvt. Ltd., Mumbai, India),and VITEK-2® Compact (Biomérieux, France). Virulence factors, such as adherence to buccal epithelial cells (ABEC), biofilm formation, hemolytic activity, and production of coagulase enzyme were also tested.
Results: Mean age of the patients was 38.46 years with a male-female ratio of 1.36:1. In total, 137 Candida isolates were recovered; 45.3%, 19.7%, and 13.9% of the isolates were isolated from urine, vaginal swabs, and oropharyngeal swabs, respectively. Moreover, 55(40.1%) isolates were those of C. albicans and 82 (59.9%) isolates belonged to NCAC spp.,with C. tropicalis (23.4%) contributing highest among NCAC species. Furthermore, C. albicans (3; 50%) was the most common spp. in cases of candidemia. Haemolysin production (85.5%) and ABEC (78.2%) were the major virulence factors in C. albicans. C.tropicalis (59.4%) and C. dubliniensis (50%) showed maximum ABEC. Biofilm forming capacity was higher in C. tropicalis (78.1%) than C. albicans (67%).
Conclusion: Results of this study suggest varied prevalence and virulence based on geographical locations, even within a subcontinent. It clearly indicates the emergence of the NCAC spp. and their predominance in different body fluids. Identification of Candida to the spp. level should become a routine in all laboratories.



1. Garber G. An overview of fungal infections. Drugs. 2001;
61)Suppl 1):1-12.
2. Deorukhkar SC, Saini S, Mathew S. Non-
albicans Candida
Infection: an emerging threat. Interdiscip Perspect Infect Dis.
2014; 2014:615958.
3. Deorukhkar S, Saini S. Virulence markers and antifungal
susceptibility profile of
Candida glabrata: an emerging
pathogen. Microbiol Res J Int. 2014; 4(1):39-49.
4. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis:
a persistent public health problem. Clin Microbiol Rev. 2007;
5. Snydman DR. Shifting patterns in the epidemiology of
Candida infections. Chest. 2003; 123(5 Suppl):
6. Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM,
Mendes Giannini MJ.
Candida species: current epidemiology,
pathogenicity, biofilm formation, natural antifungal products and
new therapeutic options. J Med Microbiol. 2013; 62(Pt 1):10-24.
7. Sullivan DJ, Henman MC, Moran GP, O'Neill LC, Bennett DE,
Shanley DB, et al. Molecular genetic approaches to
identification, epidemiology and taxonomy of
species. J Med Microbiol. 1996; 44(6):399-408.
8. Sachin CD, Ruchi K, Santosh S. In vitro evaluation of
proteinase, phospholipase and haemolysin activities of
species isolated from clinical specimens. Int J Med Biomed Res.
2012; 1(2):153-7.
9. Yapar N. Epidemiology and risk factors for invasive candidiasis.
Ther Clin Risk Manag. 2014; 10:95-105.
10. Tille PM. Infections of the urinary tract. Bailey and Scottls
diagnostic microbiology. 13
th ed. Maryland Heights, Missouri:
Mosby Elsevier; 2017 . P. 987-8.
11. Byadarahally Raju S, Rajappa S. Isolation and identification of
Candida from the oral cavity. ISRN Dent. 2011; 2011:487921.
12. Deorukhkar SC, Saini S. Laboratory approach for diagnosis of
candidiasis through ages. Int J Curr Microbiol Appl Sci. 2014;
13. Kimura LH, Pearsall NN. Adherence of
Candida albicans to
human buccal epithelial cells. Infect Immunity. 1978; 21(1):64-8.
14. Yigit N, Aktas E, Dagistan S, Ayyildiz A. Investigating biofilm
production, coagulase and hemolytic activity in
Candida species
isolated from denture stomatitis patients. Eurasian J Med. 2011;
15. Luo G, Samaranayake LP, Yau JY.
Candida species exhibit
differential in vitro hemolytic activities. J Clin Microbiol. 2001;
16. Rodrigues AG, Pina-Vaz C, Costa-de-Oliveira S, Tavares C.
Expression of plasma coagulase among pathogenic
species. J Clin Microbiol. 2003; 41(12):5792-3.
17. Baird D.
Staphylococcus: cluster forming gram positive cocci.
Mackie McCartney Pract Med Microbiol. 1996; 14:245-61.
18. Alvarez-Lerma F, Nolla-Salas J, León C, Palomar M, Jordá R,
Carrasco N, et al.
Candiduria in critically ill patients admitted to
intensive care medical units. Intensive Care Med. 2003;
19. Kauffman CA.
Candiduria. Clin Infect Dis. 2005; 41(Suppl
20. Toner L, Papa N, Aliyu SH, Dev H, Lawrentschuk N, Al-Hayek
Candida growth in urine cultures: a contemporary analysis of
species and antifungal susceptibility profiles. QJM. 2016 ;
21. Gharaghani M, Taghipour S, Halvaeezadeh M, Mahmoudabadi
Candiduria; a review article with specific data from Iran.
Turk J Urol. 2018 ; 44(6):445-52.
22. Paul N, Mathai E, Abraham OC, Michael JS, Mathai D. Factors
associated with candiduria and related mortality. J Infect. 2007 ;
23. Mohanty S, Xess I, Hasan F, Kapil A, Mittal S, Tolosa JE.
Prevalence & susceptibility to fluconazole of
Candida species
causing vulvovaginitis. Indian J Med Res. 2007; 126(3):216-9.
24. Anwar KP, Malik A, Subhan KH. Profile of candidiasis in HIVinfected patients. Iran J Microbiol. 2012; 4(4):204-9.
25. Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y,
Edmond MB, et al
. Nosocomial bloodstream infections due to
Candida spp. in the USA: species distribution, clinical features
and antifungal susceptibilities. Int J Antimicrob Agents. 2014;
43(1): 78-81 .
26. Calderone RA, Fonzi WA. Virulence factors of
. Trends Microbiol. 2001; 9(7):327-35.
27. Mane A, Pawale C, Gaikwad S, Bembalkar S, Risbud A.
Adherence to buccal epithelial cells, enzymatic and hemolytic
activities of
Candida isolates from HIV-infected individuals.
Med Mycol. 2011; 49(5):548-51.
28. Seneviratne CJ, Jin L, Samaranayake LP. Biofilm lifestyle of
Candida: a mini review. Oral Dis. 2008; 14(7):582-90.
29. Silva S, Negri M, Henriques M, Oliveira R, Williams DW,
Azeredo J.
Candida glabrata, Candida parapsilosis and Candida
: biology, epidemiology, pathogenicity and antifungal
resistance. FEMS Microbiol Rev. 2012; 36(2):288-305.
30. Rodloff C, Koch D, Schaumann R. Epidemiology and antifungal
resistance in invasive candidiasis. Eur J Med Res. 2011;
31. Pakshir K, Zomorodian K, Karamitalab M, Jafari M, Taraz H,
Ebrahimi H. Phospholipase, esterase and hemolytic activities of
Candida spp. isolated from onychomycosis and oral lichen
planus lesions. J Mycol Med. 2013; 23(2):113-8.
32. Noori M, Dakhili M, Sepahvand A, Davari N. Evaluation of
esterase and hemolysin activities of different
species isolated from vulvovaginitis cases in Lorestan
Province, Iran. Curr Med Mycol. 2017; 3(4):1-5.
Volume 7, Issue 2
June 2021
Pages 8-13
  • Receive Date: 25 February 2021
  • Revise Date: 06 May 2021
  • Accept Date: 10 May 2021
  • First Publish Date: 31 May 2021
  • Publish Date: 01 June 2021